Review: taking Zofran and Hydroxyzine pamoate together


Summary

Drug interactions are reported among people who take Zofran and Hydroxyzine pamoate together. This review analyzes the effectiveness and drug interactions between Zofran and Hydroxyzine pamoate. It is created by eHealthMe based on reports of 72 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 26,888 users)

Hydroxyzine Pamoate

Hydroxyzine pamoate has active ingredients of hydroxyzine pamoate. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine pamoate 1,194 users)

On Aug, 31, 2016

72 people who take Zofran, Hydroxyzine Pamoate are studied.


Number of reports submitted per year:

Zofran and Hydroxyzine pamoate drug interactions.

Drug effectiveness over time:

Zofran:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zofran:
  • female: 100.0% - (2 of 2 people)
  • male: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • acute myeloid leukaemia recurrent
  • cytomegalovirus infection
  • delirium
  • diabetes mellitus
  • diarrhoea
  • dry eye
  • epigastric discomfort
  • febrile neutropenia
  • circulatory collapse
  • acute graft versus host disease
1 - 6 months:
  • autoimmune hepatitis
  • chest pain
  • headaches
  • memory loss
  • disease progression
  • malignant neoplasm progression
6 - 12 months:
  • nausea
1 - 2 years:
  • nausea
not specified:
  • pain
  • nausea
  • diarrhoea
  • vomiting
  • asthenia
  • gait disturbance
  • oedema peripheral
  • anxiety
  • arthralgia
  • cholelithiasis

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • diarrhoea
  • vomiting
  • asthenia
  • gait disturbance
  • arthralgia
  • cholelithiasis
  • hypokalaemia
  • oedema peripheral
male:
  • renal failure acute
  • febrile neutropenia
  • nausea
  • acute respiratory distress syndrome
  • device related infection
  • autoimmune hepatitis
  • chest pain
  • circulatory collapse
  • myalgia
  • rash

Most common drug interactions by age *:

10-19:
  • acute graft versus host disease
  • cytomegalovirus infection
  • diabetes mellitus
  • activated partial thromboplastin time abnormal
  • activated partial thromboplastin time prolonged
  • amenorrhoea
  • blood albumin decreased
  • blood fibrinogen abnormal
  • blood fibrinogen increased
  • congenital anomaly
20-29:
  • pulmonary embolism
  • colitis ischaemic
  • deep vein thrombosis
  • thrombosis
  • renal failure acute
  • anuria
  • ascites
  • blood bilirubin increased
  • blood culture positive
  • cholelithiasis
30-39:
  • acute respiratory distress syndrome
  • device related infection
  • renal failure acute
  • acute respiratory failure
  • alopecia
  • bacterial sepsis
  • base excess decreased
  • blood bicarbonate increased
  • blood ph decreased
  • blood ph increased
40-49:
  • abdominal pain
  • anastomotic complication
  • colitis ulcerative
  • crohn's disease
  • device occlusion
  • diarrhoea haemorrhagic
  • drug effect decreased
  • gastrointestinal perforation
  • impaired healing
  • injection site pain
50-59:
  • pain
  • nausea
  • arthralgia
  • chest pain
  • asthenia
  • fall
  • gait disturbance
  • joint swelling
  • migraine
  • myalgia
60+:
  • diarrhoea
  • hypokalaemia
  • alanine aminotransferase increased
  • constipation
  • diverticulitis
  • fatigue
  • musculoskeletal pain
  • nausea
  • oedema peripheral
  • pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zofran and Hydroxyzine pamoate?

Can you answer these questions?

More questions for: Zofran, Hydroxyzine pamoate

You may be interested in these reviews

More reviews for: Zofran, Hydroxyzine pamoate

On eHealthMe, Zofran (ondansetron hydrochloride) is often used to treat nausea. Hydroxyzine pamoate (hydroxyzine pamoate) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.